Cargando…
Review of the 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation—What Has Changed and How Does This Affect Daily Practice
The high prevalence of atrial fibrillation (AF) in the overall population and its association with substantial morbidity, increased mortality and health care cost has instigated significant basic and clinical research efforts over recent years. The publication of multiple new high-quality randomized...
Autores principales: | Tonko, Johanna B., Wright, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432123/ https://www.ncbi.nlm.nih.gov/pubmed/34501370 http://dx.doi.org/10.3390/jcm10173922 |
Ejemplares similares
-
The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2021) -
Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines
por: Polidori, M. Cristina, et al.
Publicado: (2021) -
Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
por: Kirchhof, Paulus
Publicado: (2017) -
Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)
por: Kirchhof, Paulus, et al.
Publicado: (2014) -
The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways
por: Leblanc, Kori, et al.
Publicado: (2021)